Clinical Lymphoma Myeloma & Leukemia
- ISSN:
- 2152-2650
0
h-индекс
0
Иқтибослар
26
Асарлар
0.00
2-йиллик ўртача иқтибос
Ишонч сигналлари
1 дан 3 сигнал мавжудМустақил ижобий сигналлар — ягона “предатор/қонуний” ҳукми эмас, балки яқинлашувчи тасвир.
- DOAJМаълумот йўқdoaj.org
- ОАК рўйхатиМаълумот йўқОАК
- Яроқли ISSNМавжудISSN
Бу ахборот ёрлиғи, расмий қарор эмас. Сигнал йўқлиги жазо эмас — масалан, минтақавий журнал DOAJ'да бўлмаслиги мумкин.
Вақт бўйича
Вақт бўйича таҳлил
Иқтибос шарҳи
Йиллар бўйича нашрлар (устун) ва иқтибослар (чизиқ)
- Нашрлар
- Иқтибослар
Нашр тарихи
h-индекс эволюцияси
Йиллар бўйича жамланган h-индекс
Энг кўп иқтибос қилинган асарлар
- The Clinical Efficacy of Chelation Therapy in Patients with Myelodysplastic Syndrome, Low Risk20190 иқтибос
- MDS-259: Myelodysplastic Syndrome in Uzbekistan: A Study of Prevalence20210 иқтибос
- Poster: MDS-259: Myelodysplastic Syndrome in Uzbekistan: A Study of Prevalence20210 иқтибос
- CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 иқтибос
- POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 иқтибос
- POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment20230 иқтибос
- POSTER: ALL-253 Evaluation of Aberrant Expression of CD Markers in Acute Leukemia Cells20230 иқтибос
- POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial20230 иқтибос
- MDS-580 Case Report of Myelodysplastic Neoplasm (MDS) Hiding Under Immune Thrombocytopenic Purpura (ITP)20230 иқтибос
- POSTER: ALL-296 Results of Treatment of Children With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Low-dose Chemotherapy Without Bone Marrow Transplantation in Uzbekistan20230 иқтибос